Literature DB >> 3384937

Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2).

J Freney1, W Hansen, J Etienne, F Vandenesch, J Fleurette.   

Abstract

Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2) were both isolated from the same blood culture of a 5-month-old infant, 8 days after open-heart surgery. He quickly responded to appropriate antibiotics. Carbon substrate assimilation tests and fatty acid analysis clearly differentiated these two rarely pathogenic organisms.

Entities:  

Mesh：

Year:  1988        PMID： 3384937      PMCID： PMC266575          DOI： 10.1128/jcm.26.6.1241-1243.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Characteristics of yellow-pigmented nonfermentative bacilli (groups VE-1 and VE-2) encountered in clinical bacteriology.

Authors:  G L Gilardi; S Hirschl; M Mandel
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

2.  The cytology of Pseudomonas spp. as revealed by a silver-plating staining method.

Authors:  M E RHODES
Journal:  J Gen Microbiol       Date:  1958-06

3.  Group VE-2 (Chromobacterium typhiflavum) bacteremia.

Authors:  F D Pien
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

4.  Group Ve infection: case report of group Ve-2 septicemia and literature review.

Authors:  F D Pien; E Y Chung
Journal:  Diagn Microbiol Infect Dis       Date:  1986-07       Impact factor: 2.803

5.  Characterization of saccharolytic nonfermentative bacteria associated with man.

Authors:  M J Pickett; M M Pedersen
Journal:  Can J Microbiol       Date:  1970-05       Impact factor: 2.419

6.  Prosthetic valve endocarditis caused by group Ve-1 bacteria (Chromobacterium typhiflavum).

Authors:  T O'Leary; I W Fong
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

7.  Unusual bacterium, group Ve-2, causing peritonitis in a patient on continuous ambulatory peritoneal dialysis.

Authors:  M R Silver; T P Felegie; M I Sorkin
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

8.  Group VE-1 septicemia.

Authors:  S A Berger; Y Siegman-Igra; J Stadler; A Campus
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

Review 9.  In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

10.  Cellular fatty acid composition of Pseudomonas paucimobilis and groups IIk-2, Ve-1, and Ve-2.

Authors:  S B Dees; C W Moss; R E Weaver; D Hollis
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948
View more
  18 in total

1.  Flavimonas oryzihabitans (formerly CDC group Ve-2) bacteremia in a pediatric patient on assisted ventilation.

Authors:  J Reina; J Odgardd; I Llompart; P Alomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

2.  Flavimonas oryzihabitans as a cause of ocular infection.

Authors:  P N Levett; D A Garrett; T Wickramasuriya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-07       Impact factor: 3.267

3.  Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.

Authors:  Benoît Doublet; Frédéric Robin; Isabelle Casin; Laëtitia Fabre; Anne Le Fleche; Richard Bonnet; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

4.  Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2): an emerging pathogen in peritonitis related to continuous ambulatory peritoneal dialysis?

Authors:  J W Bendig; P J Mayes; D E Eyers; B Holmes; T T Chin
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

5.  Haemorrhagic papular rash associated to Flavimonas oryzihabitans bacteraemia in a child.

Authors:  A Kansouzidou; C Charitidou; E Poubrou; V D Daniilidis; H Tsagaropoulou
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

Review 6.  Infections due to Flavimonas oryzihabitans: case report and literature review.

Authors:  J Esteban; M L Valero-Moratalla; R Alcazar; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

7.  Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

8.  Isolation of Flavimonas oryzihabitans (CDC group Ve-2) from catheter-induced bacteremia in an immunocompromised patient.

Authors:  R Mutters; H Köppler; T Krause
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

9.  Chryseomonas luteola identified as the source of serious infections in a Moroccan University Hospital.

Authors:  Wafae Chihab; Ahmed S Alaoui; Mohamed Amar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Application of gas-liquid chromatography to the routine identification of nonfermenting gram-negative bacteria in clinical specimens.

Authors:  A Veys; W Callewaert; E Waelkens; K Van den Abbeele
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.